REGISTERED
on 02 Jan 2024
Last Applicant/ Owned by
Porton Science Park, Bybrook Road,
GB
Serial Number
79351356 filed on 20th Jul 2022
Registration Number
7256771 registered on 02th Jan 2024
Correspondent Address
Christel E. Harlacher
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
K
Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or fac Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical and healthcare services relating to ophthalmic diseases and disorders; medical and health care services relating to diabetic macular edema; medical and healthcare services relating to angioedema; medical and healthcare services relating to hereditary angioedema; medical and healthcare services relating to diseases and disorders mediated by the contact activation system; medical and healthcare services relating to plasma kallikrein or factor XIIa mediated diseases or disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or factor XIIa mediated diseases or disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Medical and surgical instruments and apparatus for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders; drug delivery devices for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular edema; pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79351356
Mark Type
No Service Mark
Attorney Docket Number
No 2051953-0003
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Design Code(s)
26.01.21 -
Circles that are totally or partially shaded
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.06 -
Diagonal line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Apr 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 04th Apr 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 04th Apr 2024 | FINAL DISPOSITION PROCESSED |
| 02th Apr 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 02th Jan 2024 | REGISTERED-PRINCIPAL REGISTER |
| 02th Jan 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 17th Oct 2023 | NOTIFICATION PROCESSED BY IB |
| 17th Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 17th Oct 2023 | PUBLISHED FOR OPPOSITION |
| 27th Sep 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |